These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

362 related items for PubMed ID: 17346227

  • 1. Critical enzymes involved in endocannabinoid metabolism.
    Basavarajappa BS.
    Protein Pept Lett; 2007; 14(3):237-46. PubMed ID: 17346227
    [Abstract] [Full Text] [Related]

  • 2. New insights into endocannabinoid degradation and its therapeutic potential.
    Bari M, Battista N, Fezza F, Gasperi V, Maccarrone M.
    Mini Rev Med Chem; 2006 Mar; 6(3):257-68. PubMed ID: 16515464
    [Abstract] [Full Text] [Related]

  • 3. Endocannabinoid dysregulation in the pancreas and adipose tissue of mice fed with a high-fat diet.
    Starowicz KM, Cristino L, Matias I, Capasso R, Racioppi A, Izzo AA, Di Marzo V.
    Obesity (Silver Spring); 2008 Mar; 16(3):553-65. PubMed ID: 18239598
    [Abstract] [Full Text] [Related]

  • 4. Endocannabinoid metabolic pathways and enzymes.
    Ligresti A, Cascio MG, Di Marzo V.
    Curr Drug Targets CNS Neurol Disord; 2005 Dec; 4(6):615-23. PubMed ID: 16375679
    [Abstract] [Full Text] [Related]

  • 5. Dual blockade of FAAH and MAGL identifies behavioral processes regulated by endocannabinoid crosstalk in vivo.
    Long JZ, Nomura DK, Vann RE, Walentiny DM, Booker L, Jin X, Burston JJ, Sim-Selley LJ, Lichtman AH, Wiley JL, Cravatt BF.
    Proc Natl Acad Sci U S A; 2009 Dec 01; 106(48):20270-5. PubMed ID: 19918051
    [Abstract] [Full Text] [Related]

  • 6. Endocannabinoid regulation in human endometrium across the menstrual cycle.
    Scotchie JG, Savaris RF, Martin CE, Young SL.
    Reprod Sci; 2015 Jan 01; 22(1):113-23. PubMed ID: 24819878
    [Abstract] [Full Text] [Related]

  • 7. Alterations in endocannabinoid tone following chemotherapy-induced peripheral neuropathy: effects of endocannabinoid deactivation inhibitors targeting fatty-acid amide hydrolase and monoacylglycerol lipase in comparison to reference analgesics following cisplatin treatment.
    Guindon J, Lai Y, Takacs SM, Bradshaw HB, Hohmann AG.
    Pharmacol Res; 2013 Jan 01; 67(1):94-109. PubMed ID: 23127915
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Differential regulation of endocannabinoid synthesis and degradation in the uterus during embryo implantation.
    Wang H, Xie H, Sun X, Kingsley PJ, Marnett LJ, Cravatt BF, Dey SK.
    Prostaglandins Other Lipid Mediat; 2007 Feb 01; 83(1-2):62-74. PubMed ID: 17259073
    [Abstract] [Full Text] [Related]

  • 10. Blockade of endocannabinoid-degrading enzymes attenuates neuropathic pain.
    Kinsey SG, Long JZ, O'Neal ST, Abdullah RA, Poklis JL, Boger DL, Cravatt BF, Lichtman AH.
    J Pharmacol Exp Ther; 2009 Sep 01; 330(3):902-10. PubMed ID: 19502530
    [Abstract] [Full Text] [Related]

  • 11. Brain regional cannabinoid CB(1) receptor signalling and alternative enzymatic pathways for 2-arachidonoylglycerol generation in brain sections of diacylglycerol lipase deficient mice.
    Aaltonen N, Riera Ribas C, Lehtonen M, Savinainen JR, Laitinen JT.
    Eur J Pharm Sci; 2014 Jan 23; 51():87-95. PubMed ID: 24012970
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Modulators of endocannabinoid enzymic hydrolysis and membrane transport.
    Ho WS, Hillard CJ.
    Handb Exp Pharmacol; 2005 Jan 23; (168):187-207. PubMed ID: 16596775
    [Abstract] [Full Text] [Related]

  • 14. Guineensine is a novel inhibitor of endocannabinoid uptake showing cannabimimetic behavioral effects in BALB/c mice.
    Nicolussi S, Viveros-Paredes JM, Gachet MS, Rau M, Flores-Soto ME, Blunder M, Gertsch J.
    Pharmacol Res; 2014 Feb 23; 80():52-65. PubMed ID: 24412246
    [Abstract] [Full Text] [Related]

  • 15. Endocannabinoid modulation by FAAH and monoacylglycerol lipase within the analgesic circuitry of the periaqueductal grey.
    Lau BK, Drew GM, Mitchell VA, Vaughan CW.
    Br J Pharmacol; 2014 Dec 23; 171(23):5225-36. PubMed ID: 25041240
    [Abstract] [Full Text] [Related]

  • 16. Discovery and development of endocannabinoid-hydrolyzing enzyme inhibitors.
    Minkkilä A, Saario S, Nevalainen T.
    Curr Top Med Chem; 2010 Dec 23; 10(8):828-58. PubMed ID: 20370710
    [Abstract] [Full Text] [Related]

  • 17. Inactivation and biotransformation of the endogenous cannabinoids anandamide and 2-arachidonoylglycerol.
    Yates ML, Barker EL.
    Mol Pharmacol; 2009 Jul 23; 76(1):11-7. PubMed ID: 19389920
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Biology of endocannabinoid synthesis system.
    Wang J, Ueda N.
    Prostaglandins Other Lipid Mediat; 2009 Sep 23; 89(3-4):112-9. PubMed ID: 19126434
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.